WDR5
PDB:3SMR
Revision
Revision Type:created
Revised by:created
Revision Date:created
Entry Clone Accession:GI:16554627
Entry Clone Source:MGC
SGC Clone Accession:WDR5:APC041-G05:C36415
Tag:N-terminal: His-tag with integrated TEV protease site:MHHHHHHSSGRENLYFQG
Host:E.coli BL21 (DE3) codon plus RIL (Stratagen).
Construct
Prelude:Sequence:gTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC
Vector:pET28-MHL
Growth
Medium:Antibiotics:Procedure:WDR5 was expressed in E.coli BL21 (DE3)codon plus RIL in TB medium in the presence of 50 μg/ml of kanamycin. Cell weregrown at 37oC to an OD600 of 1.5 and induced by isopropyl-1-thio-D-galactopyranoside(IPTG), final concentration 1 mM and incubated overnight at 15oC.
Purification
ProcedureThe crude extract was cleared by centrifugation. The clarifiedlysate was loaded onto 5 ml HiTrap Chelating column (Amersham Biosciences), chargedwith Ni2+. The column was washed with 10 CV of 20 mM HEPES, pH 7.4, containing250 mM NaCl, 50 mM imidazole, 5% glycerol, and the protein was eluted with elutionbuffer (20 mM HEPES pH 7.4, 250 mM NaCl, 250 mM imidazole, 5% glycerol).The protein was loaded on Superdex200 column (26x60) (Amersham Biosciences),equilibrated with 20 mM PIPES buffer, pH 6.5, and 250 mM NaCl, at flow rate 4 ml/min. The fractions containing WDR5 were pooled and treated with TEV protease toremove His-Tag. The protein was further purified to homogeneity by ion-exchangechromatography on Source 30S column (10x10) (Amersham Biosciences), equilibratedwith buffer 20 mM PIPES, pH 6.5, and eluted with linear gradient of NaCl up to 500 mMconcentration (20CV). Purification yield was 11 mg of the protein per 1L of culture.
Enzymatic treatment: TEV cleavage.
Extraction
ProcedureCells were harvested by centrifugation at 12,227 Xg. The cell pellets were frozen in liquid nitrogen and stored at -80˚C. For thepurification, 11 g of the cell paste was thawed and resuspended in 110 ml lysis buffer(50 mM HEPES, pH 7.4, 250 mM NaCl, 5 mM imidazol, 2 mM β-mercaptoethanol, 5%glycerol) with protease inhibitor (1mM phenylmethyl sulfonyl fluoride, PMSF). Thecells were lysed by passing through Microfluidizer (Microfluidics Corp.) at 20,000 psi.
Concentration:18 mg/ml
LigandMassSpec:expected MW = 34245.9 Da, measured MW= 34248.5767 Da.
Crystallization:Purified WDR5 (10 mg/mL) was complexed with compound SGC8271at 1:5 molar ratio of protein:compound and crystallized using the sitting drop vapordiffusion method at 20 °C by mixing 1 µl of the protein solution with 1 µl of the reservoirsolution containing 25% PEG3350, 0.2 M NH4OAc, 0.1 M BisTris, pH 6.5.
NMR Spectroscopy:Data Collection:Data Processing:
